CMC Product Development
Let Frontage help move your pharmaceutical program from the preclinical phase into clinical development with expert synthesis, preparation and testing of your active pharmaceutical ingredient (API) or organic compound for administration in vivo.
Advance your program with Frontage by accessing our CMC services:
Custom synthesis and development of active pharmaceutical ingredients (APIs)
Reference standards for finished product development
Analytical services for various dosage forms of related compounds
Analysis of stability, dissolution and other characteristics
Producing solid, semi-solid, liquid and sterile dosage forms
Operating under current Good Manufacturing Practices (cGMP), the Frontage manufacturing facilities are designed with the goal of producing solid oral dosage forms, as well as semi-solid, liquid and sterile products ranging from a few units up to 140 kg for solid dose, 300 kg for semi-solid and liquids and up to 20 liters for aseptic processes.
Our scientific and regulatory consulting group can provide the expertise needed to support the filing of INDs, NDAs and ANDAs with the Food and Drug Administration. Additionally, Frontage scientists have the required knowledge and expertise to support the technical transfer of the process and analytical methods to a sponsor’s facility.